Which obesity-associated parameters can better reflect the risk of the occurrence of the anastomotic leakage?
Zeyang ChenJiejin YangZining LiuYuyang ZhangJiali SunPengyuan WangPublished in: Scandinavian journal of gastroenterology (2020)
Purpose: We investigated which obesity-associated parameters can better predict the risk of anastomotic leakage (AL) in rectal cancer patients that underwent anterior resection of the rectum.Method: Patients (n = 589) who underwent anterior resection of the rectum with a primary anastomosis were included in this study, including 44 patients with AL and 545 without AL. Univariate analysis was used to compare demographic characteristics and to select risk factors that were used in one-to-one propensity score matching (PSM). Obesity-associated parameters, including preoperative body mass index (BMI), visceral fat area (VFA), subcutaneous fat area (SFA), total fat area (TFA), VFA/TFA ratio, serum cholesterol, and triglycerides, were compared between the two groups after PSM.Results: Sex, neoadjuvant chemotherapy, operation time, and anastomosis level from the anal verge were risk factors for AL (p < .05). After the PSM, BMI, VFA, SFA, TFA, VFA/TFA, and serum cholesterol showed no significant difference between the two group (p > .05). However, the level of serum triglycerides was an independent risk factor for AL (p = .024, odds ratio = 2.95).Conclusions: Serum triglycerides have potential as a predictive indicator for AL, which may improve the treatment and outcomes of patients with AL.
Keyphrases
- body mass index
- rectal cancer
- neoadjuvant chemotherapy
- insulin resistance
- weight gain
- end stage renal disease
- metabolic syndrome
- weight loss
- adipose tissue
- locally advanced
- risk factors
- ejection fraction
- newly diagnosed
- type diabetes
- peritoneal dialysis
- prognostic factors
- risk assessment
- lymph node
- radiation therapy
- squamous cell carcinoma
- physical activity
- fatty acid
- high density
- patient reported outcomes
- high resolution
- mass spectrometry
- combination therapy